Transient cardiac arrest in a child with Down syndrome during anesthesia induction with sevoflurane: a case report
© The Author(s) 2016
Received: 1 March 2016
Accepted: 3 August 2016
Published: 8 August 2016
This report describes a case of transient cardiac arrest in a child with Down syndrome. The cardiac arrest occurred during induction of anesthesia with sevoflurane. To the best of our knowledge, this is the first such report.
A 14-year-old boy was scheduled to undergo dental treatment under general anesthesia because of his mental disorder. He had congenital atrial and ventricular septal defects and patent ductus arteriosus, which had been repaired previously. Therefore, we anticipated no problems with his cardiovascular system during the perioperative period. Because the sedation administered before the insertion of an intravenous catheter and arterial line was insufficient to induce an anesthetic effect, general anesthesia was induced by using a mixture of sevoflurane (5 %) with oxygen in nitrous oxide. A few minutes after the induction of anesthesia, the patient unexpectedly experienced bradycardia (heart rate <30 beats/min), and his electrocardiography findings indicated asystole. After a few minutes of cardiopulmonary resuscitation, the patient’s heart rate returned to normal.
We postulated that the asystole was triggered by a dysfunction in the autonomic cardiac regulation and sympathetic activation, which often occurs in patients with Down syndrome, and due to the use of high concentrations of sevoflurane. In future cases of pediatric patients with Down syndrome, with or without heart disease, the concentration of sevoflurane administered during surgery should be increased gradually. Moreover, an intravenous catheter should be promptly inserted to administer anticholinergic drugs as quickly as possible in order to prevent transient cardiac arrest.
Down syndrome is one of the most common genetic disorders associated with trisomy in chromosome 21, with an incidence of about 1 in 800 live births. Approximately 50 % of children with Down syndrome are born with congenital heart diseases [1, 2]. Consequently, the perioperative management of patients with both Down syndrome and heart disease is focused on the management of the risk factors of cardiovascular disease. General anesthesia with sevoflurane is routinely used in children with Down syndrome and congenital heart diseases because of its favorable hemodynamic stability. However, some cases of severe bradycardia and hypotension during sevoflurane induction have been reported in children with Down syndrome, even in those without congenital heart disease [3–6]. Such complications appear to be related to the dysfunction of the sympathetic nervous system, which is peculiar among patients with Down syndrome [3–6]. Although there have been previous reports of bradycardia and hypotension associated with sevoflurane use in children with Down syndrome, there are no reports on transient cardiac arrest occurring without a preceding cardiac event, hypoxia, or hypercapnia. We present the case of a pediatric patient with Down syndrome who experienced transient cardiac arrest during anesthesia induction with sevoflurane.
The Institutional Review Board of Fukuoka Dental College approved this study.
The patient was a 14-year-old boy (height = 150 cm, weight = 54 kg) with Down syndrome, atrial septal defect (ASD), ventricular septal defect (VSD), and patent ductus arteriosus (PDA). His congenital heart defects were surgically repaired at 5 months of age. Thereafter, he was followed up once a month with echocardiography. No structural or mechanical problems and dysfunction were noted in his cardiovascular system, such as a left-right shunt. The most recent findings of his echocardiogram were as follows: all chambers were balanced; good wall motion; no asynergy; normal interventricular septum; left ventricular ejection fraction, 85 %; left ventricular end-diastolic dimension, 42 mm; no valve regurgitations; and no abnormal flow resulting from the ASD, VSD, and PDA. The attending physician of the pediatric cardiology section categorized the patient’s condition as grade 1 heart failure according to the New York Heart Association functional classification system. Therefore, we assessed the patient in accordance with the diagnosis of the attending physician. The patient’s intelligence quotient was 35, and his intellectual level was that of a 1.5-year-old child.
The patient’s parents were informed about the risks of general anesthesia before they provided consent. We determined that the perioperative risk in this patient was similar to that in other patients who had undergone corrective surgery for ASD, VSD, and PDA because there were no structural or mechanical problems with his cardiovascular system. He did not present with any risk factors for complications resulting from intubation, such as macroglossia, micronesia, and brevicollis. Although we did not check for dislocation of the first cervical vertebra, it did not seem necessary to restrain his head for airway management. He consumed no food for 6 h and no liquid for 2 h before the operation. We decided to intramuscularly inject midazolam before surgery and to gradually and incrementally induce anesthesia by means of inhalation of sevoflurane with oxygen and nitrous oxide through a face mask, after which an intravenous catheter and arterial line were inserted. To prevent infective endocarditis, we also planned to administer intravenous antibiotics during the operation.
At 9:30 a.m. on the day of the operation, the patient was administered 10 mg midazolam intramuscularly as a sedative. At 10:00 a.m., he was brought to the operating room on a gurney. However, he was not sedated because the midazolam had not taken effect. Moreover, because of his inability to emotionally cope with the environmental change, he acted violently against physical restraint and was in danger of falling from the operating table; therefore, it became necessary to perform anesthesia induction immediately. We therefore administered sevoflurane (5 %) to induce general anesthesia as rapidly as possible. We intended to decrease the concentration of sevoflurane as soon as the patient’s movements were controlled. Because of the patient’s violent behavior, we could not measure his BP, HR, SpO2, and body temperature and could not perform the cardiac evaluation with insertion of an intravenous catheter and arterial line before the induction. The anesthetist who performed the anesthesia induction had 15 years of experience at the time. Three anesthetists, who are all co-authors of this paper, performed the anesthesia induction.
After this incident, the operating dentist scheduled his dental treatment under sedation using midazolam and physical restraint.
Our case demonstrates the possibility for patients with Down syndrome to experience cardiac arrest during induction of general anesthesia. We believe that the asystole was triggered by the dysfunction in autonomic cardiac regulation and sympathetic activation; these issues are often observed in patients with Down syndrome and after the use of sevoflurane. Other possible causes (including a cardiac event; hypoxia; repaired ASD, VSD, and PDA; and RBBB) were not suspected to be responsible for the cardiac arrest.
The findings of a previous report on anesthesia-related cardiac arrest in children with congenital heart disease showed that the conditions of most of the affected patients were unrepaired (59 %) or palliated (26 %) . Our patient had no structural or mechanical problems with his heart; however, he possibly had other dysfunctions in the cardiovascular system, as has been reported in other patients [8–10]. Agiovlasitis et al.  suggested that the decreased HR caused by orthostatic stress in patients with Down syndrome without cardiac disease was related to dysfunction in autonomic cardiac regulation and the blunting of sympathetic activation. Chromosome 21, three copies of which are inherited in Down syndrome, controls the size of certain cells and their number per unit area, which may explain the cardiac dysfunction and blunting of sympathetic activation [9, 10]. Therefore, dysfunctional sympathetic nerve activities may have caused the bradycardia that preceded asystole in our patient.
Bradycardia is the most frequently observed arrhythmia that precedes cardiac arrest in children, according to a registry report on pediatric perioperative cardiac arrest, in which the high incidence of cardiovascular arrest during anesthesia was highlighted . Green et al.  found that the onset of bradycardia occurred significantly earlier with the induction of high-concentration sevoflurane than with incremental induction. We suspect that a severe vasovagal reflex caused the asystole subsequent to bradycardia in our patient. Usually, the ECG R-R intervals in the vasovagal reflex prolong gradually and lead to sinus arrest . In our patient, asystole occurred after severe bradycardia, and the R-R intervals were gradually prolonged. This case was thus apparently caused by a severe vasovagal reflex related to dysfunction in autonomic cardiac regulation and the blunting of sympathetic activation. However, because suitable mask ventilation was performed, and normal end-tidal CO2 and SpO2 levels were confirmed, the cause of cardiac arrest was determined to be factors other than hypoxia or hypercapnia.
We considered the associations of asystole and RBBB with congenital heart disease. According to a previous study, RBBB is well correlated with high pulmonary/systemic blood flow ratio in patients with ASD . However, the ASD in this patient had already been surgically repaired. Another study showed that in cases with surgical VSD repair, RBBB might be associated with right ventricular dysfunction . However, the authors of that study concluded that after VSD repair, biventricular systolic and diastolic dysfunction may develop irrespective of the presence of RBBB . Therefore, the dysfunction may not be directly related to the RBBB. For the aforementioned reasons, we consider that RBBB with congenital heart disease may not be directly related to the asystole in the present case.
In previous studies, an anticholinergic drug was administered to counter bradycardia [5, 15]; however, it is unclear whether anticholinergic drugs have a protective effect against bradycardia in patients with Down syndrome. We postulate that it is necessary to place an catheter to quickly administer anticholinergic drugs. Alternatively, intramuscular anticholinergic drugs should be administered and the HR should increase before beginning mask induction because severe bradycardia may rapidly progress to asystole, as observed in our case.
We expected that sedation would be sufficient for intravenous and arterial line cannulation. Indeed, we considered that inducing a sufficient level of sedation would keep the patient in a calm state for any intervention. However, in this case, the administration of additional intramuscular midazolam might have resulted in a more effective outcome. Therefore, if we were reoperating on this patient under general anesthesia, we would administer sufficient quantities of intramuscular midazolam before inserting an intravenous catheter. We would subsequently increase the concentration of sevoflurane gradually or perform rapid induction with the use of intravenous anesthetics.
This case demonstrates the possibility for patients with Down syndrome to experience cardiac arrest during induction of general anesthesia. We conclude that there is a possibility in pediatric cases of Down syndrome, presenting with or without heart disease, to experience transient cardiac arrest during anesthesia induction with sevoflurane.
ASD, atrial septal defect; BP, blood pressure; CPR, cardiopulmonary resuscitation; ECG, electrocardiogram; HR, heart rate; PDA, patent ductus arteriosus; RBBB, right bundle branch block; SpO2, peripheral oxygen saturation; VSD, ventricular septal defect
We thank the Section of Dentistry for the Disabled, Section of Pediatrics, and Section of Internal Medicine for providing technical support during the perioperative period.
KN, ST, and KT carried out the general anesthesia induction and cardiopulmonary resuscitation. KN drafted the manuscript. ST conceived of the study and participated in its design and coordination and helped in drafting the manuscript. KT helped in drafting the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the parents of the patient for the publication of this case report and any accompanying images. A copy of the written consent form is available for review by the Editor-in-Chief of this journal.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Centers for Disease Control and Prevention. Improved national prevalence estimates for 18 selected major birth defects, United States, 1999-2001. Morb Mortal Wkly Rep. 2006;54:1301–5.Google Scholar
- Van Praagh R, Papagiannis J, Bar-El Y, Schiwint O. The heart in Down syndrome: pathologic anatomy. Baltimore, MD: Brookes Publishing Co.; 1996.Google Scholar
- Borland LA, Colligan J, Brandom BW. Frequency of anesthesia-related complications in children with Down syndrome under general anesthesia for noncardiac procedures. Paediatr Anaesth. 2004;14:733–8.View ArticlePubMedGoogle Scholar
- Murat I, Constant I, Maud’huy H. Perioperative anaesthetic morbidity in children: a database of 24,165 anaesthetics over a 30-month period. Paediatr Anaesth. 2004;14:158–66.View ArticlePubMedGoogle Scholar
- Kraemer FW, Stricker PA, Gurnaney HG, McClung H, Meador MR, Sussman E, et al. Bradycardia during induction of anesthesia with sevoflurane in children with Down syndrome. Anesth Analg. 2010;111:1259–63.View ArticlePubMedGoogle Scholar
- Bai W, Voepel-Lewis T, Malviya S. Hemodynamic changes in children with Down syndrome during and following inhalation induction of anesthesia with sevoflurane. J Clin Anesth. 2010;22:592–7.View ArticlePubMedGoogle Scholar
- Ramamoorthy C, Haberkern CM, Bhananker SM, Domino KB, Posner KL, Campos JS, et al. Anesthesia-related cardiac arrest in children with heart disease: data from the Pediatric Perioperative Cardiac Arrest (POCA) registry. Anesth Analg. 2010;110:1376–82.View ArticlePubMedGoogle Scholar
- Agiovlasitis S, Baynard T, Pitetti KH, Fernhall B. Heart rate complexity in response to upright tilt in persons with Down syndrome. Res Dev Disabil. 2011;32:2102–7.View ArticlePubMedGoogle Scholar
- Recalde AL, Landing BH, Lipsey AI. Increased cardiac muscle fiber size and reduced cell number in Down syndrome: heart muscle cell number in Down syndrome. Pediatr Pathol. 1986;6:47–53.View ArticlePubMedGoogle Scholar
- Landing BH, Shankle WR. Reduced number of skeletal muscle fiber nuclei in Down syndrome: speculation on a “shut off” role of chromosome 21 in control of DNA and nuclear replication rates, possibly via determination of cell surface area per nucleus. Birth Defects Orig Artic Ser. 1982;18:81–7.PubMedGoogle Scholar
- Green DH, Townsend P, Bagshaw O, Stokes MA. Nodal rhythm and bradycardia during inhalation induction with sevoflurane in infants: a comparison of incremental and high-concentration techniques. Br J Anaesth. 2000;85:368–70.View ArticlePubMedGoogle Scholar
- Mizuno J, Mizuno S, Ono N, Yajima C, Arita H, Hanaoka K. Sinus arrest during laryngoscopy for induction of general anesthesia with intravenous fentanyl and propofol. Masui. 2005;54:1030–3.PubMedGoogle Scholar
- Somura J, Nakagawa M, Ukiami M, Sagawa H, Furukawa O, Hoshino S, et al. Relationship between electrocardiographic signs and shunt volume in atrial septal defect. Pediatr Int. 2015;57:535–40.View ArticlePubMedGoogle Scholar
- Karadeniz C, Atalay S, Demir F, Tutar E, Ciftci O, Ucar T, et al. Does surgically induced right bundle branch block really effect ventricular function in children after ventricular septal defect closure? Pediatr Cardiol. 2015;36:481–8.View ArticlePubMedGoogle Scholar
- Wark HJ, Overton JH, Marian P. The safety of atropine premedication in children with Down’s syndrome. Anaesthesia. 1983;38:871–4.View ArticlePubMedGoogle Scholar